Clinical efficacy of <i>SARS‐CoV‐2 Omicron</i>‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Michael Karbiener, Gerhard Kindle, Isabelle Meyts, Mikko R. J. Seppänen, Fabio Candotti, Marta Kamieniak, Reinhard Ilk, Thomas R. Kreil, Markus G. Seidel, null null

Journal title: Journal of Medical Virology

Journal number: 96

Journal publisher: John Wiley & Sons Inc.

Published year: 2024

DOI identifier: 10.1002/jmv.29738

ISSN: 0146-6615